Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer
Interventions: DRUG: Bosutinib|DRUG: exemestane|DRUG: Exemestane
Sponsor: Pfizer